Role of NeuroD1 on the Negative Regulation of Pomc Expression by Glucocorticoid

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Apr 14

PMID 28406939

Citations 10

Authors

Rehana Parvin

Akiko Saito-Hakoda

Hiroki Shimada

Kyoko Shimizu

Erika Noro

Yasumasa Iwasaki

Ken Fujiwara

Atsushi Yokoyama

Akira Sugawara

Affiliations

Soon will be listed here.

Abstract

The mechanism of the negative regulation of proopiomelanocortin gene (Pomc) by glucocorticoids (Gcs) is still unclear in many points. Here, we demonstrated the involvement of neurogenic differentiation factor 1 (NeuroD1) in the Gc-mediated negative regulation of Pomc. Murine pituitary adrenocorticotropic hormone (ACTH) producing corticotroph tumor-derived AtT20 cells were treated with dexamethasone (DEX) (1-100 nM) and cultured for 24 hrs. Thereafter, Pomc mRNA expression was studied by quantitative real-time PCR and rat Pomc promoter (-703/+58) activity was examined by luciferase assay. Both Pomc mRNA expression and Pomc promoter activity were inhibited by DEX in a dose-dependent manner. Deletion and point mutant analyses of Pomc promoter suggested that the DEX-mediated transcriptional repression was mediated via E-box that exists at -376/-371 in the promoter. Since NeuroD1 is known to bind to and activate E-box of the Pomc promoter, we next examined the effect of DEX on NeuroD1 expression. Interestingly, DEX dose-dependently inhibited NeuroD1 mRNA expression, mouse NeuroD1 promoter (-2.2-kb) activity, and NeuroD1 protein expression in AtT20 cells. In addition, we confirmed the inhibitory effect of DEX on the interaction of NeuroD1 and E-box on Pomc promoter by chromatin immunoprecipitation (ChIP) assay. Finally, overexpression of mouse NeuroD1 could rescue the DEX-mediated inhibition of Pomc mRNA expression and Pomc promoter activity. Taken together, it is suggested that the suppression of NeuroD1 expression and the inhibition of NeuroD1/E-box interaction may play an important role in the Gc-mediated negative regulation of Pomc.

Citing Articles

Identification of gene mutations associated with type 1 diabetes by next-generation sequencing in affected Palestinian families.

Bawatneh A, Darwish A, Eideh H, Darwish H Front Genet. 2024; 14:1292073.

PMID: 38274107 PMC: 10808782. DOI: 10.3389/fgene.2023.1292073.

Pathogenesis, clinical features, and treatment of plurihormonal pituitary adenoma.

Cai Y, Liu S, Zhao X, Ren L, Liu X, Gang X Front Neurosci. 2024; 17:1323883.

PMID: 38260014 PMC: 10800528. DOI: 10.3389/fnins.2023.1323883.

Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing's Syndrome.

Nieman L Endocr Rev. 2021; 43(5):852-877.

PMID: 34849663 PMC: 9512149. DOI: 10.1210/endrev/bnab046.

Differential Effects of Fkbp4 and Fkbp5 on Regulation of the Gene in Murine AtT-20 Corticotroph Cells.

Kageyama K, Iwasaki Y, Watanuki Y, Niioka K, Daimon M Int J Mol Sci. 2021; 22(11).

PMID: 34072036 PMC: 8199270. DOI: 10.3390/ijms22115724.

Tumor Shrinkage by Metyrapone in Cushing Disease Exhibiting Glucocorticoid-Induced Positive Feedback.

Tsujimoto Y, Shichi H, Fukuoka H, Yamamoto M, Sato I, Imanishi T J Endocr Soc. 2021; 5(6):bvab055.

PMID: 34061117 PMC: 8143664. DOI: 10.1210/jendso/bvab055.

References

POULIN G, Turgeon B, Drouin J . NeuroD1/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene. Mol Cell Biol. 1997; 17(11):6673-82. PMC: 232521. DOI: 10.1128/MCB.17.11.6673. View

Kumar R, Thompson E . Gene regulation by the glucocorticoid receptor: structure:function relationship. J Steroid Biochem Mol Biol. 2005; 94(5):383-94. DOI: 10.1016/j.jsbmb.2004.12.046. View

Karalis K, Venihaki M, Zhao J, van Vlerken L, Chandras C . NF-kappaB participates in the corticotropin-releasing, hormone-induced regulation of the pituitary proopiomelanocortin gene. J Biol Chem. 2004; 279(12):10837-40. DOI: 10.1074/jbc.M313063200. View

Maira M, Martens C, Philips A, Drouin J . Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol Cell Biol. 1999; 19(11):7549-57. PMC: 84765. DOI: 10.1128/MCB.19.11.7549. View

Drouin J, Trifiro M, Plante R, Nemer M, Eriksson P, Wrange O . Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription. Mol Cell Biol. 1989; 9(12):5305-14. PMC: 363695. DOI: 10.1128/mcb.9.12.5305-5314.1989. View

Jenks B . Regulation of proopiomelanocortin gene expression: an overview of the signaling cascades, transcription factors, and responsive elements involved. Ann N Y Acad Sci. 2009; 1163:17-30. DOI: 10.1111/j.1749-6632.2008.03620.x. View

Smith E, Blalock J . Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon. Proc Natl Acad Sci U S A. 1981; 78(12):7530-4. PMC: 349302. DOI: 10.1073/pnas.78.12.7530. View

Huang H, Liu M, El-Hodiri H, Chu K, Jamrich M, Tsai M . Regulation of the pancreatic islet-specific gene BETA2 (neuroD) by neurogenin 3. Mol Cell Biol. 2000; 20(9):3292-307. PMC: 85623. DOI: 10.1128/MCB.20.9.3292-3307.2000. View

Saito-Hakoda A, Uruno A, Yokoyama A, Shimizu K, Parvin R, Kudo M . Effects of RXR Agonists on Cell Proliferation/Apoptosis and ACTH Secretion/Pomc Expression. PLoS One. 2015; 10(12):e0141960. PMC: 4695086. DOI: 10.1371/journal.pone.0141960. View

10.

Miyata T, Maeda T, Lee J . NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus. Genes Dev. 1999; 13(13):1647-52. PMC: 316850. DOI: 10.1101/gad.13.13.1647. View

11.

Dumonteil E, Laser B, Constant I, Philippe J . Differential regulation of the glucagon and insulin I gene promoters by the basic helix-loop-helix transcription factors E47 and BETA2. J Biol Chem. 1998; 273(32):19945-54. DOI: 10.1074/jbc.273.32.19945. View

12.

Drouin J . 60 YEARS OF POMC: Transcriptional and epigenetic regulation of POMC gene expression. J Mol Endocrinol. 2016; 56(4):T99-T112. DOI: 10.1530/JME-15-0289. View

13.

Shinozuka Y, Okada M, Oki T, Sagane K, Mizui Y, Tanaka I . Altered expression of HES-1, BETA2/NeuroD, and PDX-1 is involved in impaired insulin synthesis induced by glucocorticoids in HIT-T15 cells. Biochem Biophys Res Commun. 2001; 287(1):229-35. DOI: 10.1006/bbrc.2001.5573. View

14.

Lamolet B, Poulin G, Chu K, Guillemot F, Tsai M, Drouin J . Tpit-independent function of NeuroD1(BETA2) in pituitary corticotroph differentiation. Mol Endocrinol. 2004; 18(4):995-1003. DOI: 10.1210/me.2003-0127. View

15.

Cerf M . Transcription factors regulating beta-cell function. Eur J Endocrinol. 2006; 155(5):671-9. DOI: 10.1530/eje.1.02277. View

16.

Sharma A, Moore M, Marcora E, Lee J, Qiu Y, Samaras S . The NeuroD1/BETA2 sequences essential for insulin gene transcription colocalize with those necessary for neurogenesis and p300/CREB binding protein binding. Mol Cell Biol. 1998; 19(1):704-13. PMC: 83927. DOI: 10.1128/MCB.19.1.704. View

17.

Zhang Y, Chen B, Hou X, Guan G, Liu G, Liu H . Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats. Chin Med J (Engl). 2007; 120(11):988-95. View

18.

Axelrod J, Reisine T . Stress hormones: their interaction and regulation. Science. 1984; 224(4648):452-9. DOI: 10.1126/science.6143403. View

19.

Liu M, Pereira F, Price S, Chu M, Shope C, Himes D . Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems. Genes Dev. 2000; 14(22):2839-54. PMC: 317056. DOI: 10.1101/gad.840500. View

20.

Maliza R, Fujiwara K, Tsukada T, Azuma M, Kikuchi M, Yashiro T . Effects of retinoic acid on growth hormone-releasing hormone receptor, growth hormone secretagogue receptor gene expression and growth hormone secretion in rat anterior pituitary cells. Endocr J. 2016; 63(6):555-61. DOI: 10.1507/endocrj.EJ16-0086. View